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OBJECTIVE: The role of Ulinastatin in neuronal injury after cardiopulmonary resuscitation has not been
elucidated. We aim to evaluate the effects of Ulinastatin on inflammation, oxidation, and neuronal injury in
the cerebral cortex after cardiopulmonary resuscitation.
METHODS: Ventricular fibrillation was induced in 76 adult male Wistar rats for 6 min, after which
cardiopulmonary resuscitation was initiated. After spontaneous circulation returned, the rats were split into
two groups: the Ulinastatin 100,000 unit/kg group or the PBS-treated control group. Blood and cerebral cortex
samples were obtained and compared at 2, 4, and 8 h after return of spontaneous circulation. The protein levels
of tumor necrosis factor alpha (TNF-a) and interleukin 6 (IL-6) were assayed using an enzyme-linked
immunosorbent assay, and mRNA levels were quantified via real-time polymerase chain reaction.
Myeloperoxidase and Malondialdehyde were measured by spectrophotometry. The translocation of nuclear
factor-kB p65 was assayed by Western blot. The viable and apoptotic neurons were detected by Nissl and
terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL).
RESULTS: Ulinastatin treatment decreased plasma levels of TNF-a and IL-6, expression of mRNA, and
Myeloperoxidase and Malondialdehyde in the cerebral cortex. In addition, Ulinastatin attenuated the
translocation of nuclear factor-kB p65 at 2, 4, and 8 hours after the return of spontaneous circulation.
Ulinastatin increased the number of living neurons and decreased TUNEL-positive neuron numbers in the cortex
at 72 h after the return of spontaneous circulation.
CONCLUSIONS: Ulinastatin preserved neuronal survival and inhibited neuron apoptosis after the return of
spontaneous circulation in Wistar rats via attenuation of the oxidative stress response and translocation of
nuclear factor-kB p65 in the cortex. In addition, Ulinastatin decreased the production of TNF-a, IL-6,
Myeloperoxidase, and Malondialdehyde.
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& INTRODUCTION
Patients who have been successfully resuscitated after
cardiac arrest (CA) typically have a poor prognosis and a high
risk of post-resuscitation disease that shares many features
with severe sepsis (1). As early as 3 hours after CA, sharp rises
in various cytokines occur in the bloodstream. High levels of
cytokines in the bloodstream may contribute to the genesis of
tissue damage that can lead to multiple organ dysfunction (1-
3). The levels of cytokines such as tumor necrosis factor alpha
(TNF-a) and interleukin 6 (IL-6) have deleterious effects
on cerebral ischemia and are closely correlated with CA
prognosis (3,4). Clinical data indicate that cytokines play a
role in ischemic stroke injury and reveal a correlation between
cytokine concentrations and neurological outcome (5,6).
Oxidant injury occurs during CA as reactive oxygen
species (ROS) increase rapidly after the return of spontaneous
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circulation (ROSC). It has been shown that ROS stimulate the
activation of nuclear factor kB (NF-kB), which is believed to
be associated with the rapid transcription of TNF-a and the
induction of apoptosis (7,8). NF-kB is translocated from the
cytoplasm to the nucleus, and its ratio increases after cerebral
ischemia and reperfusion (9), therefore contributing to
ischemia-reperfusion injury (10). In contrast, inhibition of
NF-kB is associated with neuroprotective effects (11,12);
however, it is unclear whether the activation of NF-kB and
increased production of inflammatory cytokines play a role
in neuronal injury of the brain after ROSC.
Ulinastatin (UTI), a protease inhibitor derived from human
urine, has been shown to exhibit organ-protective effects
against ischemia-reperfusion injury in the brain (13,14).
Previous studies have shown that UTI’s protective effect is
due to its anti-inflammatory and anti-oxidative stress
responses (15,16). UTI reduces the activation of NF-kB and
downregulates the expression of its related mediators (17,18).
The majority of previous studies investigated the effects of
UTI on local organ ischemia-reperfusion injury; however,
because CA/cardiopulmonary resuscitation (CPR) CPR is a
type of systemic ischemia-reperfusion injury, the role of UTI
may be more complicated than what occurs in local organ
ischemia-reperfusion injury.
Therefore, in this study, we aimed to evaluate the effects
of UTI on the injured cerebral cortex in Wistar rats after
CA/CPR and to observe its potential therapeutic effect to
provide a scientific basis for its use in the treatment of
neuronal injury after ROSC.
& MATERIALS AND METHODS
This study was approved by the Animal Investigation
Committee of Sun Yat-sen University and was performed in
accordance with the Animal Research Reporting In Vivo
Experiments guidelines on animal research (19).
Animal preparation
After overnight fasting (with free access to water), 76
healthy male Wistar rats aged 15-16 months and weighing
360.5-416.5 g were anesthetized by intraperitoneal injection
of pentobarbital (30 mg/kg; Sigma, Natick, MA, USA).
Tracheal intubation was performed under direct vision
using indirect illumination to initiate mechanical ventilation
(Harvard Rodent Ventilator; Harvard Apparatus, Holliston,
MA). Ventilation parameters were adjusted according to
arterial blood gas results to maintain the pCO2 in the 35-45
mmHg range.
A 24-Gauge retained needle (BD Intima IITM VeinTM;
SuZhou BD Medical Appliance Co., Ltd., SuZhou, P.R.
China) was inserted into the right femoral vein to establish a
transfusion passage. The right femoral artery was cannu-
lated using a needle filled with a physiological salt solution
containing 5 IU/mL of bovine heparin (Jiangsu biochem-
istry company, Nanjing, China). Arterial blood pressure was
continuously measured with a high-sensitivity pressure
transducer (Kombidyn Monitoring Set; Braun, Melsungen,
Germany). All data were recorded for subsequent analysis
using a BIOPAC MP150 data acquisition system (model
MP150, version 3.8.1; Goleta, CA).
Induction of ventricular fibrillation
The methods for induction of ventricular fibrillation
(VF) were described previously (20-22). Briefly, two
acupuncture needles were trans-cutaneously inserted into
the epicardium between the fourth rib of the left sternal
border and the third rib of the right sternal border. VF was
induced by applying an external transthoracic alternating
current (50 Hz, 6 V) to the needles for 10 seconds. After
successful induction of VF, the ventilator was discon-
nected. Six minutes after VF, manual chest compression
and mechanical ventilation were initiated. Rats were
randomly divided into two groups (n = 38 in each group):
the VF + PBS group and the VF + UTI group. Animals
designated to the VF + UTI group received 100,000 units/
kg UTI (Tianpu Biochemistry and Medicine Corporation,
Guangzhou, P. R. China) intravenously. The dose of
100,000 units/kg UTI has been used for organ-protective
effects in prior studies (23-25). Animals in the VF + PBS
group received a volume of PBS equivalent to the volume
of UTI received by animals in the VF + UTI group. External
chest compression was performed using an external chest
compression machine for small animals (developed in our
laboratory) at a rate of 200 compressions per min with
equal compression-relaxation and a depth of compression
equal to one-third of the anteroposterior chest diameter. If
resuscitation was not achieved after 2 min of CPR, a single
dose of epinephrine at 20 mg/kg was given every 3 min.
ROSC was defined as the return of supraventricular
rhythm with a mean aortic pressure of 60 mmHg or higher
for a minimum of 10 min. If ROSC was not achieved
by 15 min after resuscitation, resuscitation efforts were
discontinued.
Six rats per group were randomly chosen and were
painlessly sacrificed by over-anesthetization 2, 4, and 8 h
after ROSC. The brains were removed and the cerebral
cortices dissected. Subsequently, samples were flash-frozen
in liquid nitrogen and transferred to a -80 C˚ freezer for
storage.
Cytokine measurement
Before CPR and at 2, 4, and 8 h after ROSC, blood samples
(0.5 ml) were collected in sodium citrate tubes and
immediately centrifuged at 1,500 x g for 5 min. The plasma
levels of TNF-a and IL-6 were analyzed using commercially
available enzyme-linked immunosorbent assay (ELISA) kits
(Rapidbio; West Hills, CA, USA).
Quantitation of TNF-a and IL-6 concentrations and
MPO and MDA activities in the cerebral cortex
Tissue from the cerebral cortex was homogenized, and
proteins were extracted using a lysis buffer (Product
No. 2355; Cell Signaling Technology, USA). Protein concen-
trations were determined with a bicinchoninic acid (BCA)
assay kit (Bioteke Corporation, Beijing, P. R. China). The
tissue concentrations of TNF-a and IL-6 were quantified by
enzyme-linked immunosorbent assay (ELISA) as described
above. Myeloperoxidase (MPO) activity was determined by
measuring the absorbance at 460 nm using a custom assay kit
(Institute of Jiancheng Biological Engineering, Nanjing, P. R.
China). The Malondialdehyde (MDA) concentration was
measured with an MDA detection kit (Institute of Jiancheng
Biological Engineering, Nanjing, P. R. China) by diluting the
samples 1:10 in assay reagents or in cool normal saline (for an
absorbance blank) and measuring the absorbance at 586 nm
using a spectrophotometer.
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Total RNA extraction, reverse transcription, and
quantitative RT-PCR
Total RNA was isolated from the cerebral cortex using
Trizol (Invitrogen, Shanghai, P. R. China) according to the
manufacturer’s instructions. Briefly, 50 mg of cerebral cortex
was homogenized in a buffered phenol solution. Nucleic
acids were recovered from the lysate by the addition of
chloroform (Sigma), centrifugation, and removal of the
aqueous layer. Nucleic acids were then precipitated from
the aqueous layer by adding absolute ethanol, and the
sample was passed through the provided glass fiber filter
column by centrifugation. The sample was washed and
eluted with 50 ml of RiboPure solution. Next, 1 ml (40 units)
of RNase inhibitor (Promega, Madison, WI, USA) was
added to each sample. The RNA quality was checked by
agarose gel electrophoresis, and 2 mg of total RNA was
treated with DNase Turbo (Ambion, Roche, West End,
Australia) according to the manufacturer’s instructions.
After DNase inactivation, cDNA was synthesized by reverse
transcription (RT) with/without the SuperScriptH III One-
Step RT-PCR System with PlatinumH Taq High Fidelity
(Invitrogen) and 10 mM random hexamer primers.
Quantitative real time polymerase chain reaction (qPCR)
was performed with an iCycler iQ Real-Time PCR Detection
System (Bio-Rad) using SYBR Green I as a double-stranded
DNA-specific dye. RT-PCR was performed using the follow-
ing primer sequences: b-actin-F: GCGCTCGTCGT
CGACAAC and b-actin-R: ATACCCACCA TCACACCCT;
TNF-a-F: CCACCACGCTCTTCTGTC and TNF-a-R: GCC-
CATTT GGG AACTTCT; and IL-6-F: TCACAGAGGATA-
CCACCCA and IL-6-R: AGAATTGCCATTGCACAAC. RT-
PCR was performed under the following conditions: 50 C˚ for-
15 min; 95 C˚ for 15 min; 40 cycles of 94 C˚ for 15 sec, 55 C˚ for
45 sec, 72 C˚ for 1 min; and a final 10 min extension at 72 C˚.
RT-PCR was performed at the minimum cycle numbers
necessary to observe bands (40 cycles for TNF-a and IL-6; 28
for b-actin) and to avoid saturation of the PCR products (9700
Sequence Detection System and ABI PRISM 310 Genetic
Analyzer, Applied Biosystems, USA). The expression of
mRNA was quantified as the ratio of 2DCt(TNF-a or IL-6)/
2DCt(b-actin), where DCt(TNF-a or IL-6) and DCt(b-actin)
represent differences between the threshold cycle (Ct) values
of the UTI-treated and UTI-untreated RNA samples for TNF-a
or IL-6 and b-actin, respectively.
Separation of cytoplasmic and nuclear proteins
Tissue extracts were prepared using CERA cytoplasmic
and nuclear extraction reagents (Bioteke Corporation,
Beijing, P. R. China) according to the manufacturer’s
instructions.
Table 1 - Physiologic and CPR requisite parameters in the
two groups.
VF + PBS VF + UTI p-value
BW (g) 320 (304, 337) 318 (304, 327) 0.419
HR (times/min) 413 (381, 422) 381 (370, 422) 0.215
MAP (mmHg) 1.40 (1.05, 2.48) 2.43 (1.48, 2.82) 0.167
BLS (min) 83 (71, 94) 80 (72, 86) 0.754
DF (times) 1 (0, 2) 2 (0, 2) 0.603
AD dose (mg) 20.7 (17.7, 27.5) 19.0 (16.7, 28.5) 0.351
BW: body weight, HR: heart rate, MAP: mean arterial pressure, BLS: basic
life support, DF: defibrillation, AD: adrenalin.
Figure 1 - UTI decreased TNF-a and IL-6 plasma levels after ROSC. Treatment with UTI after ROSC effectively decreased TNF-a and IL-6
production in the VF + UTI group; the TNF-a and IL-6 plasma levels were lower in the VF + UTI group than in the VF + PBS group at each
time point after ROSC (n=22 at 2 h, 16 at 4 h, and 10 at 8 h after ROSC in the VF + PBS group; n=32 at 2 h, 26 at 4 h, and 20 at 8 h after
ROSC in VF + UTI group). * VF + PBS versus VF + UTI, p,0.05.
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Western blot analysis of NF-kB expression
The expression of NF-kB protein in the cytoplasm
and nucleus was determined by Western blot analysis.
Cytoplasmic and nuclear protein samples containing 50 mg
of total protein for each lane were mixed with loading
buffer and boiled for 5 min. Samples were then loaded onto
gradient sodium dodecyl sulfate polyacrylamide gels, and
electrophoresis was performed using a Mini Protean II
Dual-Slab Cell (Bio Rad, Hercules CA, USA). Membranes
were subsequently incubated with primary rabbit anti-rat
NF-kB p65 antibodies (Santa Cruz Biotechnology, CA,
USA) at a dilution of 1:500, anti-PCNA (Proteintech Group,
Newcastle-upon-Tyne, UK) at a dilution of 1:500, and
glyceraldehyde 3-phosphate dehydrogenase (anti-GAPDH)
(Sigma-Aldrich Company, St. Louis, MO, USA) at a
dilution of 1:1000 overnight at 4 C˚. Afterwards, membranes
were washed for 15 min and incubated with horseradish
peroxidase-conjugated secondary polyclonal goat antibo-
dies raised against rat IgG (Sevac, Prague, Czech Republic)
at a dilution of 1:1000 for 1 h at room temperature. The
membranes were then washed for 15 min in TBST,
incubated with chemiluminescence substrate (Applygen
Technologies Inc., Beijing, P. R. China), and exposed to
radiographic film. Densities at specific molecular weights
were measured using National Institutes of Health image
analysis software.
Nissl and TUNEL staining
Animals were painlessly sacrificed while under deep
anesthesia at 72 h after ROSC. The brains were removed for
cryofixation before embedding and sectioning. Afterwards,
4-mm-thick brain sections were cut coronally in the cortex
at the temporal lobe level. Nissl staining was performed
to count the number of living neurons in the cortex.
Terminal deoxynucleotidyl transferase dUTP nick end
labeling (TUNEL) was performed using the In Situ Cell
Death Detection Kit (Roche Applied Science, Mannheim,
Germany). Three sections from each animal and six
standardized fields in each section were randomly selected
and analyzed. The Nissl- and apoptotic-positive neurons in
each cortex section were counted per 4006 400-pixel area
under 40X magnification by light microscopy (OLYMPUS
BX51; OLYMPUS IMAGING CORP, Japan) (20).
Statistical analysis
The experimental data were analyzed using SPSS 13.0
(SPSS Inc., Chicago, IL, USA). All data were expressed as
medians¡SD; the Mann-Whitney rank-sum test was used to
Figure 2 - UTI decreased TNF-a and IL-6 levels, MDA production, and MPO activity in the cerebral cortex after ROSC. TNF-a mRNA (A)
and IL-6 mRNA (B) expression levels were lower in the VF + UTI group than in the VF + PBS group at each time point. TNF-a (E) and IL-6
(F) protein levels were also lower in the VF + UTI group than in the VF + PBS group. Oxidative stress damage as expressed by the MDA
level was more severe in the VF + UTI group than in the VF + PBS group (C). UTI decreased MPO activity in the cerebral cortex in the VF +
UTI group after ROSC (F) (n= 6 at each time point in different groups). * VF + PBS versus VF + UTI, p,0.05.
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determine statistical significance between groups. A two-
tailed value of p,0.05 was considered statistically significant.
& RESULTS
Outcome of the induction of VF and CPR
Alternating current stimulation caused an immediate
drop of blood pressure and a loss of pulse in all 76 rats; all
animals were successfully resuscitated. Unconscious animals
required mechanical ventilation and intravenous glucose
infusion for 20-182 min after ROSC. Ten rats in the VF + PBS
group and seven rats in the VF + UTI group died of refractory
cardiac shock within 24 h. Except for the six rats that were
sacrificed 2, 4, and 8 h after ROSC in the two groups, the
remaining four rats in the VF + PBS group and the remaining
seven rats in the VF + UTI group survived for 72 h. No
difference was observed in the survival rate between the two
groups (4/10 versus 7/13, p= 0.159). No statistically signifi-
cant differences were identified between the two groups in
physiological variables, including body weight and heart
rate, or in CPR-associated parameters, including duration of
base life support and time of defibrillation (Table 1).
UTI decreased the plasma levels of TNF-a and IL-6
after ROSC
Before VF, no difference was noted in the plasma levels of
TNF-a between the VF + PBS and VF + UTI groups; however,
UTI treatment significantly decreased plasma levels of TNF-a
by 2-, 2.5-, and 2-fold at 2, 4, and 8 h after ROSC, respectively,
when compared to the VF + PBS group (Figure 1A; p= 0.009,
0.008, and 0.009, respectively). UTI treatment also significantly
reduced plasma levels of IL-6 in the VF + UTI group by 1.5-,
1.2-, and 1.7-fold at 2, 4, and 8 h after ROSC, respectively
(Figure 1B; p= 0.009, 0.012, and 0.028, respectively).
UTI decreased TNF-a, IL-6, and MDA production in
the cerebral cortex after ROSC
UTI treatment significantly decreased mRNA levels of
both TNF-a and IL-6 when compared to the VF + PBS group
at 2, 4, and 8 h after ROSC (Figure 2A, B; p= 0.003, ,0.001,
and ,0.001 for TNF-a and p= 0.003, 0.006, and 0.021 for IL-6
at 2, 4, and 8 h after ROSC, respectively). The protein levels
of both TNF-a and IL-6 were also lower in the VF + UTI
group than in the VF + PBS group (Figures 2D and 2E;
p= 0.020, 0.021, and 0.021 for TNF-a and p= 0.023, 0.021, and
0.043 for IL-6 at 2, 4, and 8 h after ROSC, respectively).
UTI treatment reduced MDA levels at 2, 4, and 8 h after
ROSC when compared to the VF + PBS group (p= 0.020,
0.024, and 0.021, respectively; Figure 2C). However, no
significant difference was noted in the MDA levels between
the two groups prior to VF.
MPO activity was measured at 2, 4, and 8 h after ROSC
with and without UTI; UTI treatment decreased neutrophil
infiltration when compared to the VF + PBS group at each
time point examined (Figure 2F; p= 0.020, 0.029, and 0.020,
respectively).
UTI attenuated the translocation of NF-kB p65 from
the cytoplasm to the nucleus.
In the VF + PBS group, the ratios of NF-kB p65
translocation were 1.08¡0.08, 1.02¡0.05, and 0.9¡0.02 at
Figure 3 - UTI attenuated the translocation of NF-kB p65 from the cytoplasm to the nucleus. The ratios of NF-kB p65 translocation in VF
+ PBS group were 1.08 (1.01, 1.15), 1.02 (0.97, 1.07), and 0.97 (0.95, 0.98) at 2, 4, and 8 h after ROSC, respectively (A). The ratios of NF-kB
p65 translocation were significantly attenuated by UTI in the VF + UTI group at 2, 4, and 8 h after ROSC (B) (n=6 at each time point in
different groups). * VF + PBS versus VF + UTI, p,0.05.
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2, 4, and 8 h after ROSC, respectively. The translocation
of NF-kB p65 from the cytoplasm to the nucleus
was significantly attenuated by UTI at 2, 4, and 8 h
after ROSC (Figure 3A, B; p= 0.021, 0.020, and 0.019,
respectively).
UTI increased the number of viable cells and
decreased the number of TUNEL-positive cells in the
cortex 72 h after ROSC.
The number of Nissl-stained cells in the cortices of rats in
the VF + PBS group was significantly lower than in the VF +
UTI group 72 h after ROSC (Figure 4A; p= 0.001). However,
the number of TUNEL-positive neurons in the cortex of the
temporal lobe in the VF + PBS group was greater than in the
VF + UTI group 72 h after ROSC (Figure 4B; p= 0.001).
& DISCUSSION
In this study, we demonstrated that treatment with UTI
after ROSC was effective in the prevention of oxidative
damage and resulted in a decreased inflammatory response
after CA induced by VF. UTI treatment significantly
decreased the level of MDA in the cortex, the ratios of NF-
kB p65 translocation from the cytoplasm to the nucleus, and
the mRNA and protein levels of TNF-a and IL-6. We also
found that UTI treatment increased the number of Nissl-
positive (i.e., living) neurons while reducing the number of
TUNEL-positive (i.e., apoptotic) cells, indicating that UTI
decreased neuronal apoptosis. These findings suggest that
attenuation of neuronal injury by UTI in a rat model of VF is
associated with inhibition of oxidative stress and activation
of the NF-kB/TNF-a signaling pathway.
Figure 4 - UTI increased the number of Nissl-stained neurons and decreased the number of TUNEL-positive cells in the cortex. Nissl
staining indicated that rat cortical cell numbers in the VF + PBS group were significantly lower than in the VF + PBS group 72 h after
ROSC (A, B). There was a greater number of TUNEL-positive neurons (indicated by the white arrow) in rat cortices in the VF + PBS group
than in the VF + UTI group 72 h after ROSC (C, D) (72 standard fields in the VF + PBS group and 126 standard fields in the VF+UTI group
were analyzed). * VF + PBS versus VF + UTI, p,0.05.
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We found that the activity of MPO in the cortex of rats in
the VF + UTI group was lower than in the VF + PBS group. It
is known that leukocyte adhesion to vessel walls and
translocation into tissues is mediated by selectins and
interstitial cell adhesion molecules, which are expressed
on the surfaces of endothelial cells. Moreover, the intracel-
lular content of MPO is constant in neutrophils, and their
accumulation was evaluated by measurement of MPO
activity. Therefore, based on our results, leukocyte infiltra-
tion to the cortex after ROSC was presumably attenuated by
UTI.
The results of this study showed that plasma concentra-
tions of TNF-a and IL-6 increased dramatically shortly after
resuscitation from VF cardiac arrest and remained elevated
during the early post-resuscitation period. Substantial
evidence from animal and human ex-vivo cardiac experi-
ments has supported the hypothesis that acute inflamma-
tion associated with ischemia-reperfusion injury is partially
caused by TNF-a and IL-6 (26). Support for this hypothesis
is based on the finding that TNF-a levels are increased in the
peritoneal macrophages collected from rats subjected to
myocardial ischemia-reperfusion injury, and TNF-a is
primarily produced by circulation-activated macrophages
in response to ischemia and reperfusion (27-29). TNF-a acts
as an important substance in the recruitment of circulating
leukocytes to the sites of inflammatory lesions; additionally,
the cytokine may be synthesized during ischemia and
released on reperfusion from the ischemic tissue itself (30),
as shown in the present study.
IL-6 is another well-known cytokine that is up-regulated
following cerebral ischemia. The serum level of IL-6 is
associated with the brain infarct volume and is a powerful
predictor of early neurological deterioration (31,32). Here,
we showed that the levels of TNF-a and IL-6, two pro-
inflammatory cytokines, are significantly lower in the
plasma and cerebral tissue obtained from UTI-treated
animals, which may explain the protective action of UTI
against post-ischemic injury.
It has been shown that the inflammatory response is
mediated by NF-kB (33), a redox-sensitive transcription
factor that can be activated by reactive oxygen and is
generated during the acute phase of reperfusion (34,35);
therefore, inhibition of NF-kB suppresses the inflammatory
response and limits injury. TNF-a and IL-6 were greatly
increased in the VF + PBS group, but their levels were
significantly lower in the VF + UTI group. This result
strongly suggests that UTI might reduce the levels of
cytokines via inhibition of NF-kB activation after ROSC;
however, direct evidence needs to be acquired with further
investigation.
In addition to the anti-inflammatory and anti-oxidative
stress effects of UTI demonstrated in this Wistar rat CA/
CPR model, other mechanisms may also contribute to the
neuroprotective action of UTI on global ischemia-reperfu-
sion in the brain (13,14). The effects of UTI on the
preservation of mitochondrial function may also be
involved in the protection of neurons from ischemia-
reperfusion injury after ROSC (36).
Study limitations
The analysis of NF-kB translocation and TNF-a and IL-6
expression in this study focused on the cerebral cortex,
which contains different types of cells, such as inflammatory
and endothelial cells, neurons, and glial cells, that all could
induce changes in NF-kB, TNF-a, and IL-6 expression after
global brain ischemia and reperfusion. Although we found
that UTI treatment reduced the tissue expression of TNF-a
and IL-6 and the translocation of NF-kB p65 from the
cytoplasm to the nucleus, we did not differentiate different
cell types in these tissue sections. In future studies, it would
be worthwhile to identify specific cellular types that are
potentially targeted by UTI after ischemia/reperfusion
stimulation.
This study was the first to demonstrate that UTI can
preserve neuronal survival and inhibit neuron apoptosis
after ROSC in Wistar rats via attenuating oxidative stress
and the translocation of NF-kB p65 from the cytoplasm to
the nucleus in the cortex, subsequently decreasing the
production of TNF-a, IL-6, MDA, and MPO. Our study will
provide the scientific basis for UTI treatment in neuronal
injury after ROSC.
& ACKNOWLEDGMENTS
This study was supported by funding from the TIANPU Fund (01200918),
NSFC (81272062), and the Science and Technology Foundation of
Guangdong Province, China (2012B031800286). The funders had no role
in the study design, data collection, analysis, decision to publish, or the
preparation of the manuscript.
& AUTHOR CONTRIBUTIONS
Hu CL, Cai J and Xia JM contributed equally to this work. Hu CL and
Jing XL conceived the idea for the study. Hu CL, Cai J and Xia JM
contributed to the design and assisted in performing the animal
experiments and sample harvests. Dai G and Zhan H contributed to the
sample measurements. Jing XL contributed to the data analysis. Hu CL
and Xia JM wrote the manuscript. Li X and Liao XX revised the
manuscript. All authors approved the final version of the manuscript.
& REFERENCES
1. Adrie C, Laurent I, Monchi M, Cariou A, Dhainaou JF, Spaulding C.
Postresuscitation disease after cardiac arrest: a sepsis-like syndrome.
Curr Opin Crit Care. 2004;10(3):208-12, http://dx.doi.org/10.1097/01.
ccx.0000126090.06275.fe.
2. Callaway CW RJC, Logue ES MMJ. Hypothermia after cardiac arrest
does not alter serum inflammatory markers. Crit Care Med.
2008;36(9):2607-12, http://dx.doi.org/10.1097/CCM.0b013e318184443b.
3. Adrie C, Adib-Conquy M, Laurent I, Monchi M, Vinsonneau C, Fitting C,
et al. Successful cardiopulmonary resuscitation after cardiac arrest as a
"sepsis-like" syndrome. Circulation. 2002;106(5):562-8, http://dx.doi.
org/10.1161/01.CIR.0000023891.80661.AD.
4. Zhao H, Li CS, Gong P, Tang ZR, Hua R, Mei X, et al. Molecular
mechanisms of therapeutic hypothermia on neurological function in
a swine model of cardiopulmonary resuscitation. Resuscitation.
2012;83(7):913-20, http://dx.doi.org/10.1016/j.resuscitation.2012.01.001.
5. Vila N, Castillo J, Davalos A, Chamorro A. Proinflammatory cytokines
and early neurological worsening in ischemic stroke. Stroke.
2000;31(10):2325-9, http://dx.doi.org/10.1161/01.STR.31.10.2325.
6. Sairanen T, Carpen O, Karjalainen-Lindsberg ML, Paetau A, Turpeinen
U, Kaste M, et al. Evolution of cerebral tumor necrosis factor-alpha
production during human ischemic stroke. Stroke. 2001;32(8):1750-8,
http://dx.doi.org/10.1161/01.STR.32.8.1750.
7. Basu S, Nozari A, Liu XL, Rubertsson S, Wiklund L. Development of a
novel biomarker of free radical damage in reperfusion injury after
cardiac arrest. FEBS Lett. 2000;470(1):1-6, http://dx.doi.org/10.1016/
S0014-5793(00)01279-5.
8. Niemann JT, Rosborough J, Youngquist S, Lewis RJ, Phan QT, Filler S.
The proinflammatory cytokine response following resuscitation in the
swine model dl depends on the method of ventricular fibrillation
induction. Acad Emerg Med. 2008;15(10):939-44, http://dx.doi.org/10.
1111/j.1553-2712.2008.00237.x.
9. Stephenson D, Yin T, Smalstig EB, Hsu MA, Panetta J, Little S, et al.
Transcription factor nuclear factor-kappa B is activated in neurons after
focal cerebral ischemia. J Cereb Blood Flow Metab. 2000;20(3):592-603,
http://dx.doi.org/10.1097/00004647-200003000-00017.
10. Nurmi A, Lindsberg PJ, Koistinaho M, Zhang W, Juettler E, Karjalainen-
Lindsberg ML, et al. Nuclear factor-kappaB contributes to infarction after
CLINICS 2013;68(9):1231-1238 Ulinastatin attenuates rats neurons injury
Hu CL et al.
1237
permanent focal ischemia. Stroke. 2004;35(4):987-91, http://dx.doi.org/
10.1161/01.STR.0000120732.45951.26.
11. Sironi L, Banfi C, Brioschi M, Gelosa P, Guerrini U, Nobili E, et al.
Activation of NF-kB and ERK1/2 after permanent focal ischemia is
abolished by simvastatin treatment. Neurobiol Dis. 2006;22(2):445-51,
http://dx.doi.org/10.1016/j.nbd.2005.12.004.
12. Valerio A, Dossena M, Bertolotti P, Boroni F, Sarnico I, Faraco G, et al.
Leptin is induced in the ischemic cerebral cortex and exerts neuroprotec-
tion through NF-kappaB/c-Rel-dependent transcription. Stroke. 2009;40
(2):610-7, http://dx.doi.org/10.1161/STROKEAHA.108.528588.
13. Koga Y, Fujita M, Tsuruta R, Koda Y, Nakahara T, Yagi T, et al. Urinary
trypsin inhibitor suppresses excessive superoxide anion radical genera-
tion in blood, oxidative stress, early inflammation, and endothelial injury
in forebrain ischemia/reperfusion rats. Neurol Res. 2010;32(9):925-32,
http://dx.doi.org/10.1179/016164110X12645013515133.
14. Yano T, Anraku S, Nakayama R, Ushijima K. Neuroprotective effect of
urinary trypsin inhibitor against focal cerebral ischemia-reperfusion
injury in rats. Anesthesiology. 2003;98(2):465-73, http://dx.doi.org/10.
1097/00000542-200302000-00028.
15. Abu-Amara M, Gurusamy K, Hori S, Glantzounis G, Fuller B, Davidson
BR. Systematic review of randomized controlled trials of pharmacolo-
gical interventions to reduce ischaemia-reperfusion injury in elective
liver resection with vascular occlusion. HPB (Oxford). 2010;12(1):4-14.
16. Koga Y, Fujita M, Tsuruta R, Koda Y, Nakahara T, Yagi T, et al. Urinary
trypsin inhibitor suppresses excessive superoxide anion radical genera-
tion in blood, oxidative stress, early inflammation, and endothelial injury
in forebrain ischemia/reperfusion rats. Neurol Res. 2010;32(9):925-32,
http://dx.doi.org/10.1179/016164110X12645013515133.
17. Wu YJ, Ling Q, Zhou XH, Wang Y, Xie HY, Yu JR, et al. Urinary trypsin
inhibitor attenuates hepatic ischemia-reperfusion injury by reducing
nuclear factor-kappa B activation. Hepatobiliary Pancreat Dis Int.
2009;8(1):53-8.
18. Wu YJ, Ling Q, Zhou XH, Wang Y, Xie HY, Yu JR, et al. Urinary trypsin
inhibitor attenuates hepatic ischemia-reperfusion injury by reducing
nuclear factor-kappa B activation. Hepatobiliary Pancreat Dis Int.
2009;8(1):53-8.
19. Kilkenny C, Browne WJ, Cuthill IC, Emerson M, Altman DG. Improving
bioscience research reporting: the ARRIVE guidelines for reporting
animal research. PLoS Biol. 2010;8(6):e1000412, http://dx.doi.org/10.
1371/journal.pbio.1000412.
20. Hu CL, Wei HY, Liu ZY, Li X, Liao XX, Li YJ, et al. Investigation of the
relationship between venticular fibrillation duration and cardiac/
neurological damage in a rabbit model of electrically induced arrhyth-
mia. J Trauma. 2010;69(6):1442-7.
21. Chun-Lin H, Jie W, Xiao-Xing L, Xing L, Yu-Jie L, Hong Z, et al. Effects of
therapeutic hypothermia on coagulopathy and microcirculation after-
cardiopulmonary resuscitation in rabbits. Am J Emerg Med.
2011;29(9):1103-10.
22. Lin JY, Liao XX, Li H, Wei HY, Liu R, Hu CL, et al. Model of cardiac arrest
in rats by transcutaneous electrical epicardium stimulation. Resuscitation.
2010;81(9):1197-204, http://dx.doi.org/10.1016/j.resuscitation.2010.05.019.
23. Wu YJ, Ling Q, Zhou XH, Wang Y, Xie HY, Yu JR, et al. Urinary trypsin
inhibitor attenuates hepatic ischemia-reperfusion injury by reducing
nuclear factor-kappa B activation. Hepatobiliary Pancreat Dis Int.
2009;8(1):53-8.
24. Shin IW, Jang IS, Lee SM, Park KE, Ok SH, Sohn JT, et al. Myocardial
protective effect by ulinastatin via an anti-inflammatory response after
regional ischemia/reperfusion injury in an in vivo rat heart model.
Korean J Anesthesiol. 2011;61(6):499-505.
25. Yano T, Anraku S, Nakayama R, Ushijima K. Neuroprotective effect of
urinary trypsin inhibitor against focal cerebral ischemia-reperfusion
injury in rats. Anesthesiology. 2003;98(2):465-73, http://dx.doi.org/10.
1097/00000542-200302000-00028.
26. Wanderer AA. Ischemic-reperfusion syndromes: biochemical and
immunologic rationale for IL-1 targeted therapy. Clin Immunol.
2008;128(2):127-32, http://dx.doi.org/10.1016/j.clim.2008.03.514.
27. Caputi AP, Squadrito F. Role of TNF-alpha and therapeutic perspectives
in bowel and myocardial ischemia/reperfusion injury. Pharmacol Res.
1992;26 Suppl 2:150-1, http://dx.doi.org/10.1016/1043-6618(92)90640-
W.
28. Lucchesi BR. Modulation of leukocyte-mediated myocardial reperfusion
injury. Annu Rev Physiol. 1990;52:561-76, http://dx.doi.org/10.1146/
annurev.ph.52.030190.003021.
29. Dinerman JL, Mehta JL. Endothelial, platelet and leukocyte interactions
in ischemic heart disease: insights into potential mechanisms and their
clinical relevance. J Am Coll Cardiol. 1990;16(1):207-22, http://dx.doi.
org/10.1016/0735-1097(90)90481-4.
30. Lavine SD, Hofman FM, Zlokovic BV. Circulating antibody against
tumor necrosis factor-alpha protects rat brain from reperfusion injury.
J Cereb Blood Flow Metab. 1998;18(1):52-8, http://dx.doi.org/10.1097/
00004647-199801000-00005.
31. Clark WM, Rinker LG, Lessov NS, Hazel K, Eckenstein F. Time course of
IL-6 expression in experimental CNS ischemia. Neurol Res. 1999;21(3):
287-92.
32. Acalovschi D, Wiest T, Hartmann M, Farahmi M, Mansmann U, Auffarth
GU, et al. Multiple levels of regulation of the interleukin-6 system in
stroke. Stroke. 2003;34(8):1864-9, http://dx.doi.org/10.1161/01.STR.
0000079815.38626.44.
33. Senftleben U, Karin M. The IKK/NF-kappa B pathway. Crit Care Med.
2002;30(1 Suppl):S18-26, http://dx.doi.org/10.1097/00003246-200201001-
00003.
34. Yu X, Patterson E, Huang S, Garrett MW, Kem DC. Tumor necrosis factor
alpha, rapid ventricular tachyarrhythmias, and infarct size in canine
models of myocardial infarction. J Cardiovasc Pharmacol. 2005;45(2):153-
9, http://dx.doi.org/10.1097/01.fjc.0000151930.12026.b7.
35. Chandrasekar B CJT, Geimer J CD, Freeman GL. Induction of nuclear
factor kappaB but not kappaB-responsive cytokine expression during
myocardial reperfusion injury after neutropenia. Free Radic Biol Med.
2000;28(11):1579-88, http://dx.doi.org/10.1016/S0891-5849(00)00273-2.
36. Zhao H, Li CS, Gong P, Tang ZR, Hua R, Mei X, et al. Molecular
mechanisms of therapeutic hypothermia on neurological function in a
swine model of cardiopulmonary resuscitation. Resuscitation. 2012;
83(7):913-20, http://dx.doi.org/10.1016/j.resuscitation.2012.01.001.
Ulinastatin attenuates rats neurons injury
Hu CL et al.
CLINICS 2013;68(9):1231-1238
1238
